Faros Drag 300 mg 100 pcs
Faros 300 mg 100 Dragee
Send a request to get a price
Not availableAnalogues of the product based on the Anatomical Therapeutic Chemical (ATC) Classification - C01EB04
Description - Faros Drag 300 mg 100 pcs
Faros 300 contains a hawthorn dry extract from leaves and flowers. Faros 300 is effective for so-called nervous heart problems, which manifest themselves as follows: palpitations, a feeling of pressure and anxiety in the heart area. Stitches in the area of ??the heart, rapid pulse and dizziness.
Swissmedic-approved patient information
Faros® 300 Dragées
Herbal medicinal product
What is Faros 300 and when is it used?
Faros 300 contains a dry extract of hawthorn leaves and flowers. Faros 300 is effective for so-called nervous heart problems, which manifest themselves as follows: palpitations, a feeling of pressure and anxiety in the heart area. Stitches in the area of ??the heart, rapid pulse and dizziness.
What should be considered?
If an irregular pulse, severe palpitations, stabbing pains in the chest area and shortness of breath occur suddenly or last longer, consult a doctor or a Doctor indicated to determine whether the heart or the vessels are organically diseased or whether the complaints are nervous.
When should Faros 300 not be used or only with caution?
Faros 300 should not be used if there is a known hypersensitivity to the active ingredient Crataegus or any of the other ingredients of the drug. There are no studies on the use of this medicine in children. It should therefore not be used in children under the age of 12. Inform your doctor, pharmacist or druggist if you suffer from other illnesses, have allergies or are taking other medicines (including those you bought yourself) or using them externally.
Can Faros 300 be taken during pregnancy or breastfeeding?
Based on previous experience, there is no known risk for the child when used as intended. However, systematic scientific investigations have never been carried out. As a precaution, you should avoid taking medicines during pregnancy and breastfeeding or ask your doctor, pharmacist or druggist for advice.
How do you use Faros 300?
The following information applies unless your doctor has prescribed Faros 300 differently. Please adhere to the instructions for use. Adults: the usual dosage is 3 times 1 dragée. Take the dragees whole with a little liquid (e.g. half a glass of water) in the morning, at noon and in the evening, preferably before meals. Faros 300 has not been tested in children under the age of 12 and adolescents; therefore this indication is not suitable for this age group. Faros 300 can be taken over a longer period of time if the doctor allows it. Follow the dosage given in the package leaflet or as prescribed by your doctor. If you think the medicine is too weak or too strong, talk to your doctor, pharmacist or druggist.
What side effects can Faros 300 have?
For Faros 300, when used as intended, occasional stomach problems have been observed, but these are harmless. If you notice side effects that are not described here, you should inform your doctor, pharmacist or druggist.
What else needs to be considered?
The medicinal product may only be used up to the end of the period marked «Exp.» on the container. designated date are used. Store at room temperature (15-25°C). Keep out of reach of CHILDREN. Your doctor, pharmacist or druggist can provide you with further information.
What does Faros 300 contain?
1 dragee contains: Extractum Crataegi 300 mg (dry extract of hawthorn leaves with flowers corresponding to at least 6% Flavonoids, calculated as hyperoside, drug-extract ratio 4-7:1, extractant 70% by volume methanol). This preparation contains additional excipients.
Approval number
54292 (Swissmedic).
Where can you get Faros 300? What packs are available?
Available in pharmacies and drugstores without a doctor's prescription. Faros 300 dragées are in original packs of 50 and 100 dragées.
Authorization holder
OM Pharma Suisse SA, Villars-sur-Glâne This leaflet was last checked by the drug authority (Swissmedic) in November 2006.
















